Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026)
Insmed (INSM) recorded quarterly Change in Acquisitions & Divestments of $284.0 million in Q1 2026, down 34.86% quarter-over-quarter from $436.0 million in Q4 2025, and down 60.61% on a YoY basis from $721.0 million in Q1 2025.
Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Insmed's Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $284.0 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 60.61% year-over-year to $284.0 million; the TTM figure through Mar 2026 stood at $1.7 billion (up 15.03% YoY), while the FY2025 annual figure was $2.1 billion, up 105.71% from the prior year.
- Change in Acquisitions & Divestments was $284.0 million for Q1 2026 at Insmed, down from $436.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $721.0 million in Q1 2025 to a low of $10.0 million in Q3 2023.
- Historically, Change in Acquisitions & Divestments has averaged $295.4 million across 5 years, with a median of $300.0 million in 2023.
- Biggest YoY gain for Change in Acquisitions & Divestments was 1100.0% in 2023; the steepest drop was 80.0% in 2023.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $25.0 million in 2022, then jumped by 1100.0% to $300.0 million in 2023, then soared by 138.67% to $716.0 million in 2024, then tumbled by 39.11% to $436.0 million in 2025, then plunged by 34.86% to $284.0 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $284.0 million (Q1 2026), $436.0 million (Q4 2025), and $425.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 284.00 Mn |
| Mar 31, 2026 | 284.00 Mn |
| Dec 31, 2025 | 436.00 Mn |
| Dec 31, 2025 | 436.00 Mn |
| Sep 30, 2025 | 425.00 Mn |
| Sep 30, 2025 | 425.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Mar 31, 2025 | 721.00 Mn |
| Mar 31, 2025 | 721.00 Mn |
| Dec 31, 2024 | 716.00 Mn |
| Dec 31, 2024 | 716.00 Mn |
| Mar 31, 2024 | 300.00 Mn |
| Mar 31, 2024 | 300.00 Mn |
| Dec 31, 2023 | 300.00 Mn |
| Dec 31, 2023 | 300.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | 20.00 Mn |
| Jun 30, 2023 | 20.00 Mn |